Skolnick Phil 4
4 · OPIANT PHARMACEUTICALS, INC. · Filed Jan 27, 2022
Insider Transaction Report
Form 4
Skolnick Phil
Chief Scientific Officer
Transactions
- Sale
Common Stock
2022-01-27$26.19/sh−1,518$39,756→ 22,445 total
Footnotes (2)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]This transaction was executed in multiple trades at prices ranging from $25.60 to $26.26. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.